Disc Medicine (IRON) Preferred Shares (2021)

Disc Medicine's (IRON) quarterly Preferred Shares came in at $141.9 million in Q4 2021.

Disc Medicine (IRON) Preferred Shares (2021) Analysis & Trends

Disc Medicine (IRON) has 1 years of Preferred Shares data on file, last reported at $141.9 million in Q4 2021.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $141.9 million in Q4 2021; TTM through Dec 2021 was $141.9 million, a N/A change from a year earlier, with the FY2021 full-year figure at $141.9 million, changed N/A from the prior year.
Preferred Shares for Q4 2021 stood at $141.9 million.
Over the last five years, Preferred Shares for IRON reached as high as $141.9 million in Q4 2021 and fell as low as $141.9 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Disc Medicine	2.90 Bn	2.90 Bn	-	-

Download Data

Date	Value
Dec 31, 2021	141.86 Mn